4.7 Article

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: a meta-analysis

Wen Wen et al.

Summary: This study conducted a meta-analysis on three new oral antivirals (molnupiravir, fluvoxamine, and Paxlovid) and their effects on mortality and hospitalization rates among COVID-19 patients. The results showed that these drugs were effective in reducing mortality and hospitalization rates by approximately 67%. Furthermore, the drugs did not increase adverse events, indicating good overall safety.

ANNALS OF MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes

Maxwell Kwok et al.

Summary: The study demonstrated that remdesivir can induce cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes at clinically relevant concentrations, including causing mitochondrial damage, reducing redox potential, suppressing mitochondrial respiration, and inducing non-mitochondrial damage, with some of these effects persisting after treatment cessation and leading to cell death.

CARDIOVASCULAR RESEARCH (2022)

Review Cardiac & Cardiovascular Systems

Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review

Maryam Nabati et al.

Summary: Remdesivir is currently the only authorized drug for COVID-19 treatment under emergency circumstances, but it may have cardiotoxic and proarrhythmic effects, especially more pronounced in patients with a history of cardiovascular diseases. Further clinical trials are needed to fully understand its safety profile and potential adverse cardiovascular effects.

CARDIOVASCULAR TOXICOLOGY (2022)

Article Medicine, Research & Experimental

Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database

Se Yong Jung et al.

Summary: The study utilized a database of cardiovascular adverse drug reactions and in vitro experiments to find that remdesivir is associated with cardiac arrest, bradycardia, and hypotension, highlighting the importance of adequate cardiovascular monitoring post remdesivir administration.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)

Article Medicine, General & Internal

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

A. Jayk Bernal et al.

Summary: This study found that early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, unvaccinated adults with Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

R. L. Gottlieb et al.

Summary: In symptomatic, nonhospitalized high-risk Covid-19 patients, a 3-day course of remdesivir significantly reduced the risk of hospitalization or death compared to placebo, with acceptable safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Biochemistry & Molecular Biology

AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models

Mihaly Varadi et al.

Summary: AlphaFold DB is an openly accessible database with high-accuracy protein-structure predictions, powered by DeepMind's AlphaFold v2.0. It provides programmatic access to a vast number of predicted structures and is expanding to cover more sequences.

NUCLEIC ACIDS RESEARCH (2022)

Review Infectious Diseases

The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies

Dang The Hung et al.

Summary: Favipiravir has shown better outcomes for hospitalized COVID-19 patients, with improved viral clearance, defervescence, chest radiological improvement, hospital discharge rates, and shorter clinical improvement time. However, there are some adverse events associated with its use. No significant differences were observed in non-hospitalized patients.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Article Chemistry, Multidisciplinary

Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice

Wen-juan Hu et al.

Summary: In this study, the pharmacokinetics and tissue distributions of Remdesivir in mice were evaluated, showing different levels and metabolic stabilities of RDV and its metabolites in blood as well as high concentrations in lung, liver, and kidney.

ACTA PHARMACOLOGICA SINICA (2021)

Article Medicine, Research & Experimental

Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs

Veronique Michaud et al.

Summary: The risk-benefit ratio for repurposed drugs to treat COVID-19 is complex, with high or moderate risk of drug-induced LQTS for most medications. Monitoring of QT interval is recommended when using certain COVID-19 repurposed drugs.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Letter Pediatrics

Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection

Maria Isabel Sanchez-Codez et al.

EUROPEAN JOURNAL OF PEDIATRICS (2021)

Article Biochemistry & Molecular Biology

N6-methyladenosine (m6A) is an endogenous A3 adenosine receptor ligand

Akiko Ogawa et al.

Summary: The study identified N-6-methyladenosine (m(6)A) as a ligand for the human adenosine A3 receptor with higher affinity than unmodified adenosine. Structural modeling revealed the amino acids required for specific binding of m(6)A to the human A3 receptor and demonstrated its dynamic release in response to cytotoxic stimuli and facilitation of type I allergy in vivo. These findings suggest m(6)A as a signaling molecule capable of activating G protein-coupled receptors (GPCRs) and triggering pathophysiological responses, a previously unreported property of RNA modifications.

MOLECULAR CELL (2021)

Editorial Material Medicine, General & Internal

Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man

Leora Branfield Day et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

Article Medicine, General & Internal

Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: Results of a multicenter national survey

Majid Haghjoo et al.

Summary: The study revealed that COVID-19 patients treated with repurposed drugs are at risk of experiencing QTc prolongation and TdP. Factors such as gender, history of heart failure, and treatment options may increase the risk of critical QT prolongation, while medications like lopinavir-ritonavir and accompanying drugs could predict the occurrence of TdP.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Article Biochemistry & Molecular Biology

Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template

Calvin J. Gordon et al.

Summary: The study found that Molnupiravir or NHC can increase the mutation frequencies in replicating coronaviruses, leading to enhanced antiviral effects; NHC-TP primarily competes with CTP for incorporation, resulting in RNA mutations; Biochemical data support a mechanism of action of Molnupiravir that is primarily based on RNA mutagenesis mediated via the template strand.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination

Aditya K. Padhi et al.

Summary: Favipiravir is a broad-spectrum inhibitor of SARS-CoV-2 RdRp, but mutations in the RdRp may lead to resistance. By focusing on the chain-termination mechanism used by favipiravir, researchers identified potential mutational hotspots and single-point mutants that could confer resistance. This study improves our understanding of how SARS-CoV-2 may adapt against favipiravir.

FEBS LETTERS (2021)

Article Multidisciplinary Sciences

Highly accurate protein structure prediction with AlphaFold

John Jumper et al.

Summary: Proteins are essential for life, and accurate prediction of their structures is a crucial research problem. Current experimental methods are time-consuming, highlighting the need for accurate computational approaches to address the gap in structural coverage. Despite recent progress, existing methods fall short of atomic accuracy in protein structure prediction.

NATURE (2021)

Article Toxicology

Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Shota Yanagida et al.

Summary: This study focused on assessing the cardiotoxicity risk of COVID-19 treatments using hiPSC-CMs, finding that hydroxychloroquine poses a proarrhythmic risk while other drugs have low risks. Therefore, hiPSC-CMs may be a useful tool for evaluating the comprehensive cardiotoxicity caused by COVID-19 treatments in nonclinical settings.

TOXICOLOGICAL SCIENCES (2021)

Review Pharmacology & Pharmacy

Adverse Cardiovascular Effects of Anti-COVID-19 Drugs

Dongling Liu et al.

Summary: COVID-19 infection has a high mortality rate in patients with preexisting cardiovascular diseases, and those with cardiovascular comorbidities have a higher risk of death. Drugs used to treat COVID-19 can have adverse effects on the heart.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

jMorp updates in 2020: large enhancement of multi-omics data resources on the general Japanese population

Shu Tadaka et al.

Summary: The Tohoku Medical Megabank project conducted genome and omics analyses on participants from two cohort studies, resulting in the creation of jMorp, a web-based database providing genome, methylome, transcriptome, and metabolome data. This resource, which includes Japanese reference sequences and allele frequencies, as well as concentration distributions of over 755 metabolites, will aid in the discovery of disease biomarkers and personalized disease prevention and early diagnosis in the general population.

NUCLEIC ACIDS RESEARCH (2021)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemical Research Methods

Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19

Minchen Chien et al.

JOURNAL OF PROTEOME RESEARCH (2020)

Editorial Material Urology & Nephrology

Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19

Meagan L. Adamsick et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Immunology

Lysolipid receptor cross-talk regulates lymphatic endothelial junctions in lymph nodes

Yu Hisano et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Review Pharmacology & Pharmacy

Novel insights into the role of urotensin II in cardiovascular disease

Joao Pereira-Castro et al.

DRUG DISCOVERY TODAY (2019)

Article Chemistry, Medicinal

The ProTide Prodrug Technology: Where Next?

Ashwag S. Alanazi et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Article Biochemistry & Molecular Biology

Human gingival fibroblast feeder cells promote maturation of induced pluripotent stem cells into cardiomyocytes

Yusuke Matsuda et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Cell Biology

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Pharmacology & Pharmacy

A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes

Hiroyuki Ando et al.

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)

Review Biochemistry & Molecular Biology

How Ligands Illuminate GPCR Molecular Pharmacology

Daniel Wacker et al.

Article Multidisciplinary Sciences

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Travis K. Warren et al.

NATURE (2016)

Article Multidisciplinary Sciences

TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling

Naoyuki Kitajima et al.

SCIENTIFIC REPORTS (2016)

Article Biochemical Research Methods

AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility

Pradeep Anand Ravindranath et al.

PLOS COMPUTATIONAL BIOLOGY (2015)

Review Cardiac & Cardiovascular Systems

Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes A Methods Overview

Christine L. Mummery et al.

CIRCULATION RESEARCH (2012)

Article Chemistry, Physical

Strength of NH...S Hydrogen Bonds in Methionine Residues Revealed by Gas-Phase IR/UV Spectroscopy

Himansu S. Biswal et al.

JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2012)

Article Biochemical Research Methods

TGFα shedding assay: an accurate and versatile method for detecting GPCR activation

Asuka Inoue et al.

NATURE METHODS (2012)

Article Pharmacology & Pharmacy

Ligand-Supported Purification of the Urotensin-II Receptor

Ann T. Du et al.

MOLECULAR PHARMACOLOGY (2010)

Review Pharmacology & Pharmacy

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

Yousuke Furuta et al.

ANTIVIRAL RESEARCH (2009)

Article Biophysics

Model of Excitation-Contraction Coupling of Rat Neonatal Ventricular Myocytes

Topi Korhonen et al.

BIOPHYSICAL JOURNAL (2009)

Review Biochemistry & Molecular Biology

Impact of GPCRs in clinical medicine: Monogenic diseases, genetic variants and drug targets

Paul A. Insel et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)

Review Multidisciplinary Sciences

hERG potassium channels and cardiac arrhythmia

MC Sanguinetti et al.

NATURE (2006)

Review Biotechnology & Applied Microbiology

Adenosine receptors as therapeutic targets

KA Jacobson et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

Review Physiology

Mammalian G proteins and their cell type specific functions

N Wettschureck et al.

PHYSIOLOGICAL REVIEWS (2005)

Review Multidisciplinary Sciences

Transduction of receptor signals by β-arrestins

RJ Leftowitz et al.

SCIENCE (2005)

Article Biochemistry & Molecular Biology

Factors contributing to decreased protein stability when aspartic acid residues are in β-sheet regions

PR Pokkuluri et al.

PROTEIN SCIENCE (2002)

Article Medicine, General & Internal

Congestive heart failure and expression of myocardial urotensin II

SA Douglas et al.

LANCET (2002)

Article Medicine, General & Internal

Timing of new black box warnings and withdrawals for prescription medications

KE Lasser et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)

Article Multidisciplinary Sciences

Gαi and Gαo are target proteins of reactive oxygen species

M Nishida et al.

NATURE (2000)